Janus Henderson Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
Janus Henderson Group's AUPH Position: Q3 2026 in Review
Janus Henderson Group opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2026: 49,331 shares worth $799K. The stake represents ﹤0.01% of the portfolio and ranks #1879 among its holdings. This is a return to the name: Janus Henderson Group previously reported a position in AUPH as recently as Q1 2026.
Janus Henderson Group first reported a position in AUPH in Q4 2021 and has held it in 19 quarters since. The position peaked at $11.5M in Q3 2025. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- Janus Henderson Group held 49,331 shares of Aurinia Pharmaceuticals worth $799K as of Q3 2026.
- Aurinia Pharmaceuticals was a new Janus Henderson Group position in Q3 2026.
- Aurinia Pharmaceuticals made up ﹤0.01% of Janus Henderson Group's portfolio in Q3 2026, its #1879 holding.
- Janus Henderson Group first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Janus Henderson Group's Aurinia Pharmaceuticals position peaked at $11.5M in Q3 2025.
- 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.